“New Bioelectronic Applied sciences Might Sign the Way forward for Medication”

“New Bioelectronic Applied sciences Might Sign the Way forward for Medication”

Rising recognition of Bioelectronic Medication as an vital new therapeutic class

SAN FRANCISCO, January 31, 2022–(BUSINESS WIRE)–Tivic Well being® Programs, Inc. (Nasdaq: TIVC), a commercial-phase healthtech firm targeted on bioelectronic medication, was one in all two corporations featured within the ABC Information story “New Bioelectronic Applied sciences Might Sign the Way forward for Medication.”

Will Carr reported on the brand new, cutting-edge bioelectronic applied sciences which are getting used immediately to assist people handle power circumstances starting from circumstances comparable to sinus ache and congestion to rheumatoid arthritis and Parkinson’s illness.

Tivic Well being is one in all two industrial corporations highlighted within the broadcast and the corporate’s sinus care product, ClearUP® Sinus Ache Aid, is the one product featured that’s commercially out there and doesn’t require surgical intervention.

In November 2021, the corporate raised $17.2 Million in its preliminary public providing to execute its progress technique by way of:

  1. Fueling gross sales of their ClearUP product by way of enlargement of promoting and social media engagement

  2. Development of the corporate’s Gen2 product

  3. Growth into new functions of its bioelectronic platform for non-invasive peripheral nerve stimulation (nPNS).

In December 2021, Tivic Well being was acknowledged by Quick Firm as a part of the publication’s inaugural “Subsequent Massive Issues in Tech 2021.” Additionally in December 2021, the corporate introduced its partnership with Mindgruve, a number one shopper advertising and marketing agency because the digital company of document.

In January 2022, Tivic Well being introduced its partnership with a number one hospital and analysis system testing an extension of the corporate’s bioelectronic platform as a brand new various to opioids for post-operative care following sinus surgical procedures.

Read Also:  A Remedy-All Scottish Hen Soup

“We proceed to see rising curiosity in bioelectronic therapies as a way to struggle illness and enhance well being,” stated Jennifer Ernst, CEO of Tivic Well being. “We’re excited to be executing on the plans specified by our IPO and seeing the broader traction as customers and healthcare professionals acknowledge the super alternatives in bioelectronic medication.”

About Tivic Well being Programs, Inc.

Tivic Well being Programs, Inc. is a commercial-phase healthtech firm delivering non-invasive bioelectronic remedies that present customers alternative within the remedy of irritation and associated circumstances. For extra info go to @TivicHealth

Ahead-Trying Statements

This press launch could comprise “forward-looking statements” which are topic to substantial dangers and uncertainties. All statements, apart from statements of historic truth, contained on this press launch are forward-looking statements. Ahead-looking statements contained on this press launch could also be recognized by way of phrases comparable to “anticipate,” “imagine,” “ponder,” “may,” “estimate,” “count on,” “intend,” “search,” “could,” “would possibly,” “plan,” “potential,” “predict,” “undertaking,” “goal,” “intention,” “ought to,” “will” “would,” or the unfavourable of those phrases or different related expressions, though not all forward-looking statements comprise these phrases. Ahead-looking statements are primarily based on Tivic Well being Programs, Inc.’s present expectations and are topic to inherent uncertainties, dangers and assumptions which are tough to foretell. Additional, sure forward-looking statements are primarily based on assumptions as to future occasions that will not show to be correct. Further info regarding Tivic Well being and its enterprise, together with a dialogue of things that might materially have an effect on the corporate working outcomes, are contained within the firm’s Registration Assertion on Type S-1 (and amendments thereto) below the heading “Danger Components,” in addition to the Firm’s subsequent filings with the Securities and Change Fee. Ahead-looking statements contained on this press launch are made as of this date, and Tivic Well being Programs, Inc. undertakes no responsibility to replace such info besides as required by relevant legislation.

Read Also:  UW Drugs Reopens 2 COVID Testing Places

View supply model on


Media Contact
Tivic Well being
Cheryl Delgreco
[email protected]

Investor Relations
[email protected]